Clinical observation of heparin binding protein for sepsis in pediatric ICU

Status

Recruiting

Phases

Early Phase 1

Study type

Observational

Source

ChiCTR

Registry ID

ChiCTR2000030364

Enrollment

Unknown

Registered

2020-02-29

Start date

2020-03-01

Completion date

Unknown

Last updated

2020-03-02

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Sepsis

Interventions

non-sepsis group vs sepsis group:N/A

Eligibility

Sex/Gender

All

Age

1 Years to 16 Years

Inclusion criteria

Inclusion criteria: 1. Aged 28 days to 16 years; 2. Patients with informed consent of Guardian.

Exclusion criteria

Exclusion criteria: 1. Anticoagulation therapy has been carried out before admission; 2. Patients with basic diseases of liver, kidney and heart; 3. History of congenital blood system diseases, coagulation dysfunction and congenital coagulation factor abnormality; 4. Those with abnormal immune function.

Design outcomes

Primary

Measure	Time frame
heparin binding protein (HBP);	—

Countries

China

Contacts

Public ContactZhang Xinping

Hunan Children's Hospital

262190@qq.com+86 13787310806

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026